Science Explorer Interactive view Map
Company · Copenhagen · Denmark

Novo Nordisk (Denmark)

In research, Novo Nordisk (Denmark) stands highest in Medicine (#1,532 of 10,443 worldwide), Health Sciences (#1,960 of 11,982 worldwide) and Life Sciences (#1,794 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Endocrinology, Diabetes and Metabolism — Endocrinology, Diabetes and Metabolism is 29.8× its share of world research.

novonordisk.comROR OpenAlex
World rank, 2022–2025
#3,639
of 28,054 · #1,207 all time
Rank in Denmark
#14
of 108
Research works
5.3k
▲ 4% vs 2013–17
Citations
227k
42.5 per fractional work
Top-10% rate
25.0%
record average 16.5%
Open access
38%
world 28%

What is Novo Nordisk (Denmark) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #1,532 of 10,443 27.0%260 #1252
Health SciencesDomain #1,960 of 11,982 27.0%274 #1496
Life SciencesDomain #1,794 of 7,800 28.5%121 #1434
Endocrinology, Diabetes and MetabolismSubfield #72 of 261 29.7%82 #50
Biochemistry, Genetics and Molecular BiologyField #1,509 of 3,579 30.4%85 #1350
Molecular BiologySubfield #1,077 of 2,175 31.3%62 #933
Physical SciencesDomain #10,312 of 12,888 18.1%72 #1037

Each strip is that field’s whole ranked pool, with the notch where Novo Nordisk (Denmark) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#1,252 #1,532
  2. Health Sciences#1,496 #1,960
  3. Life Sciences#1,434 #1,794
  4. Endocrinology, Diabetes and Metabolism#50 #72
  5. Biochemistry, Genetics and Molecular Biology#1,350 #1,509
  6. Molecular Biology#933 #1,077
  7. Physical Sciences#1,037 #10,312
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Novo Nordisk (Denmark) specialise in?

Where its research is concentrated relative to its size: Endocrinology, Diabetes and Metabolism takes 29.8× the share of its output that it takes of world research.

  1. Endocrinology, Diabetes and MetabolismSubfield · 82.4 works30×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 5 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.13× its world share, 85 worksBiochemistry, Geneti…Immunology and Microbiology: 2.14× its world share, 11 worksImmunology and Micro…Neuroscience: 1.62× its world share, 13 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.63× its world share, 6 worksPharmacology, Toxico…Chemical Engineering: 0.35× its world share, 1 worksChemical EngineeringChemistry: 1.15× its world share, 9 worksChemistryComputer Science: 0.24× its world share, 10 worksComputer ScienceEarth and Planetary Sciences: 0.07× its world share, 1 worksEarth and Planetary …Energy: 0.32× its world share, 2 worksEnergyEngineering: 0.35× its world share, 27 worksEngineeringEnvironmental Science: 0.36× its world share, 9 worksEnvironmental ScienceMaterials Science: 0.18× its world share, 3 worksMaterials ScienceMathematics: 1.83× its world share, 11 worksMathematicsPhysics and Astronomy: 0.11× its world share, 1 worksPhysics and AstronomyDentistry: 0.07× its world share, 0 worksDentistryHealth Professions: 0.83× its world share, 11 worksHealth ProfessionsMedicine: 2.65× its world share, 260 worksMedicineNursing: 0.82× its world share, 2 worksNursingVeterinary: 0.80× its world share, 1 worksVeterinaryBusiness, Management and Accounting: 0.30× its world share, 5 worksBusiness, Management…Decision Sciences: 1.16× its world share, 6 worksDecision SciencesEconomics, Econometrics and Finance: 2.09× its world share, 23 worksEconomics, Econometr…Psychology: 0.23× its world share, 4 worksPsychologySocial Sciences: 0.09× its world share, 6 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 3.6×. Every wedge is a field page.

Who are the top researchers at Novo Nordisk (Denmark)?

Ranked on the composite score, B. E. J. Pagel, Ben R. Mottelson and P. Di Vecchia lead among researchers whose main affiliation is Novo Nordisk (Denmark).

  1. 1 B. E. J. Pagel Denmark · #16,504 worldwide 651 citations · 65 works
  2. 2 Ben R. Mottelson Denmark · #34,998 worldwide 1.1k citations · 32 works
  3. 3 P. Di Vecchia Denmark · #38,202 worldwide 598 citations · 73 works
  4. 4 Helen C. Jackson Denmark · #77,132 worldwide 204 citations · 44 works
  5. 5 L. Rosenfeld Denmark · #84,655 worldwide 309 citations · 28 works
  6. 6 H. Heiselberg Denmark · #142,773 worldwide 303 citations · 29 works
  7. 7 Søren Rasmussen Denmark · #154,895 worldwide 235 citations · 22 works
  8. 8 Philip Hougaard Denmark · #184,278 worldwide 134 citations · 26 works
  9. 9 Ole H. Olsen Denmark · #217,684 worldwide 168 citations · 34 works
  10. 10 Lars Thim Denmark · #533,272 worldwide 101 citations · 15 works
All ranked researchers at Novo Nordisk (Denmark)

Which keywords describe research at Novo Nordisk (Denmark)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Type 2 Diabetes, Diabetes, Obesity, Heart Failure and Clinical Guidelines.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control64▲ 82×4 topics
  2. Insulin Therapy61▲ 99×3 topics
  3. Cardiovascular Disease50▲ 8.9×28 topics
  4. Type 2 Diabetes49▲ 43×5 topics
  5. Diabetes45▲ 18×14 topics
  6. Obesity44▲ 11×21 topics
  7. Heart Failure43▲ 20×13 topics
  8. Inflammation35▲ 3.3×61 topics
  9. Clinical Guidelines35▲ 24×4 topics
  10. Cardiovascular Outcomes34▲ 124×1 topic
  11. Glucose Control34▲ 124×1 topic
  12. Metabolic Syndrome31▲ 7.5×17 topics
  13. Type 1 Diabetes27▲ 62×2 topics
  14. Insulin Resistance23▲ 9.8×8 topics
  15. Weight Loss22▲ 26×4 topics
  16. Complications21▲ 8.3×3 topics
  17. Continuous Glucose Monitoring21▲ 88×1 topic
  18. Hypoglycemia21▲ 88×1 topic
  19. Oxidative Stress19▲ 2.3×36 topics
  20. Lifestyle Intervention19▲ 43×2 topics
  21. Diabetes Mellitus17▲ 16×5 topics
  22. Monoclonal Antibodies16▲ 35×3 topics
  23. Cardiovascular Risk15▲ 9.6×8 topics
  24. Gene Therapy15▲ 16×5 topics
  25. Biomarkers15▲ 4.2×11 topics
  26. Atherosclerosis14▲ 10×9 topics
  27. Health Outcomes14▲ 10×5 topics
  28. Therapeutic Antibodies12▲ 34×2 topics
  29. Alzheimer's Disease12▲ 8.3×5 topics
  30. Biopharmaceuticals12▲ 44×3 topics
  31. Efficacy12▲ 30×2 topics
  32. Prophylaxis12▲ 18×3 topics
  33. Inhibitors11▲ 54×2 topics
  34. Safety11▲ 92×2 topics
  35. Factor VIII11▲ 155×1 topic
  36. Hemophilia11▲ 155×1 topic
  37. Glucose Metabolism11▲ 23×2 topics
  38. Immunogenicity11▲ 50×3 topics
  39. Bariatric Surgery10▲ 61×1 topic
  40. Metabolic Surgery10▲ 61×1 topic

Which research topics does Novo Nordisk (Denmark) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Hemophilia Treatment and Research and Bariatric Surgery and Outcomes.

Diabetes Treatment and M…34Diabetes Treatment and Management: 34 fractional worksDiabetes Management and …21Diabetes Management and Research: 21 fractional worksHemophilia Treatment and…11Hemophilia Treatment and Research: 11 fractional worksBariatric Surgery and Outcomes: 10 fractional worksPancreatic function and diabetes: 10 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 9 fractional worksMetabolism, Diabetes, and Cancer: 9 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 8 fractional worksProtein purification and stability: 7 fractional worksHyperglycemia and glycemic control in critically ill and hospitalized patients: 6 fractional works
Endocrinology, Diabetes and MetabolismHematologySurgeryMolecular Biology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 34 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 21 works
  3. 3 Hemophilia Treatment and Research Hematology 11 works
  4. 4 Bariatric Surgery and Outcomes Surgery 10 works
  5. 5 Pancreatic function and diabetes Surgery 10 works
  6. 6 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 9 works
  7. 7 Metabolism, Diabetes, and Cancer Molecular Biology 9 works
  8. 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 8 works
  9. 9 Protein purification and stability Molecular Biology 7 works
  10. 10 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 6 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.5%not open61.5%

World: 28% of research is openly available.

with international co-authors41.6%domestic only58.4%

World: 19% is written across borders.

How has Novo Nordisk (Denmark)'s research output changed?

Output in 2018–2022 was 4% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Copenhagen

All research institutions in Copenhagen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.